2. Academic Validation
  3. Chromatin architecture protein HMGA2 promotes glioma malignancy via novel mechanism of IGFBP3 transcription inhibition

Chromatin architecture protein HMGA2 promotes glioma malignancy via novel mechanism of IGFBP3 transcription inhibition

  • Pathol Res Pract. 2025 Aug:272:156051. doi: 10.1016/j.prp.2025.156051.
Zenghua Liang 1,  Lu Qiao 1,  Pengyi Ma 1,  Shanshan Zhang 2,  Cuiyun Sun 3,  Wenjun Luo 3,  Lin Yu 4
Affiliations

Affiliations

  • 1 Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China; Laboratory of Molecular Immunology, Research Center of Basic Medical Science, Tianjin Medical University, Tianjin 300070, China; Tianjin Key Laboratory of Cellular and Molecular Immunology and Key Laboratory of the Educational Ministry of China, Tianjin Medical University, Tianjin 300070, China.
  • 2 Department of Radiology, Tianjin Medical University General Hospital, Tianjin, China.
  • 3 Department of Neuropathology, Tianjin Key Laboratory of Injuries, Variations and Regeneration of the Nervous System, Key Laboratory of Post-trauma Neuro-repair and Regeneration in Central Nervous System of Education Ministry, Tianjin Neurological Institute, Tianjin Medical University General Hospital, Tianjin, China.
  • 4 Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China; Laboratory of Molecular Immunology, Research Center of Basic Medical Science, Tianjin Medical University, Tianjin 300070, China; Tianjin Key Laboratory of Cellular and Molecular Immunology and Key Laboratory of the Educational Ministry of China, Tianjin Medical University, Tianjin 300070, China. Electronic address: onoblivion@tmu.edu.cn.
PMID: 40450974 DOI: 10.1016/j.prp.2025.156051
Abstract

Background: Glioma, the most prevalent primary brain tumor, is characterized by rapid proliferation, invasive growth patterns, and poor clinical outcomes. This study investigates the expression and clinical significance of chromatin architecture protein high mobility group AT-hook 2 (HMGA2) in glioma, aiming to identify potential prognostic biomarkers and therapeutic targets.

Methods: The expression of HMGA2 in different grades glioma samples was analyzed by immunohistochemistry (IHC). The functions of HMGA2 in glioma cells were identified by migration, invasion, proliferation and orthotopic tumor transplantation assays. The downstream genes of HMGA2 were screened by RNA-Seq. Chromatin immunoprecipitation-quantitative polymerase chain reaction (ChIP-qPCR), electrophoretic mobility shift assay (EMSA) and chromosome conformation capture assay (3 C) were used to analyze the downstream mechanism of HMGA2 in glioma cells.

Results: We demonstrated a positive correlation between HMGA2 expression levels and glioma malignancy grade through IHC analysis. Multivariate COX regression analysis further established HMGA2 as an independent prognostic factor in glioma. Our functional studies revealed that HMGA2 significantly enhances the migration, invasion, and proliferation capabilities of glioblastoma (GBM) cells. Mechanistically, we identified insulin-like growth factor binding protein 3 (IGFBP3) as a novel downstream target of HMGA2. HMGA2 mediates transcriptional repression of IGFBP3 through disruption of promoter-enhancer interactions, leading to subsequent activation of the PI3K/Akt signaling pathway and promotion of malignant phenotypes in GBM.

Conclusion: We confirmed a novel chromatin conformation-mediated transcriptional repression mechanism of HMGA2. By regulating IGFBP3 expression and modulating the PI3K/Akt pathway, HMGA2 emerges as a promising prognostic biomarker and potential therapeutic target for glioma patients.

Keywords

Chromatin conformation; Glioma; HMGA2; Histone modification; Promoter-enhancer interaction.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z